Interestingly, ablation of Lgr5(+) CSCs did not inhibit the growth of the primary tumor, as Lgr5(+) CSCs were continuously replenished by proliferative Lgr5(−) cancer cells, but resulted in reduced liver metastasis (CRLM) [79]. This evidence concerns the gene LGR5 and cancer.